BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15652949)

  • 41. Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases.
    Collins MJ; Dev V; Strauss BH; Fedak PW; Butany J
    J Clin Pathol; 2008 Apr; 61(4):519-23. PubMed ID: 17938162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppressive effect of fluticasone propionate on MMP expression in the nasal mucosa of allergic rhinitis patients in vivo.
    Kyo Y; Kanai K; Asano K; Hisamitsu T; Suzaki H
    In Vivo; 2006; 20(4):439-44. PubMed ID: 16900772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis.
    Sanders JS; Huitema MG; Hanemaaijer R; van Goor H; Kallenberg CG; Stegeman CA
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1927-34. PubMed ID: 17898039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
    Mannello F; Jung K; Tonti GA; Canestrari F
    Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA.
    Cho JY; Miller M; McElwain K; McElwain S; Shim JY; Raz E; Broide DH
    J Allergy Clin Immunol; 2006 Mar; 117(3):618-25. PubMed ID: 16522462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysms.
    Tsarouhas K; Tsitsimpikou C; Apostolakis S; Haliassos A; Tzardi M; Panagiotou M; Tsatsakis A; Spandidos DA
    Thromb Res; 2011 Nov; 128(5):e95-9. PubMed ID: 21802713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
    Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
    Mateos-Cáceres PJ; López-Farré AJ; Morata PC; Ramos-Mozo P; Macaya C; Serrano FJ; Moñux G
    Can J Physiol Pharmacol; 2008 Jul; 86(7):431-7. PubMed ID: 18641692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Matrix metalloproteases and their tissue inhibitor in cardiac transplantation.
    Aharinejad S; Krenn K; Zuckermann A; Schäfer R; Paulus P; Seebacher G; Wolner E; Grimm M
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):48-51. PubMed ID: 17482473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
    Chen YS; Langhammer T; Westhofen M; Lorenzen J
    Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
    Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
    Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
    Fligiel SE; Standiford T; Fligiel HM; Tashkin D; Strieter RM; Warner RL; Johnson KJ; Varani J
    Hum Pathol; 2006 Apr; 37(4):422-30. PubMed ID: 16564916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.